Hims & Hers Health (NYSE:HIMS – Get Free Report) and Bullfrog AI (NASDAQ:BFRG – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk.
Profitability
This table compares Hims & Hers Health and Bullfrog AI’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Hims & Hers Health | 6.05% | 24.67% | 9.37% |
| Bullfrog AI | N/A | -218.25% | -177.11% |
Earnings & Valuation
This table compares Hims & Hers Health and Bullfrog AI”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Hims & Hers Health | $1.48 billion | 6.02 | $126.04 million | $0.54 | 72.32 |
| Bullfrog AI | $60,000.00 | 216.79 | -$6.99 million | ($0.69) | -1.65 |
Hims & Hers Health has higher revenue and earnings than Bullfrog AI. Bullfrog AI is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of current recommendations and price targets for Hims & Hers Health and Bullfrog AI, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Hims & Hers Health | 3 | 10 | 3 | 1 | 2.12 |
| Bullfrog AI | 1 | 0 | 0 | 0 | 1.00 |
Hims & Hers Health currently has a consensus target price of $45.50, suggesting a potential upside of 16.51%. Given Hims & Hers Health’s stronger consensus rating and higher possible upside, equities analysts clearly believe Hims & Hers Health is more favorable than Bullfrog AI.
Institutional and Insider Ownership
63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 25.2% of Bullfrog AI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Risk and Volatility
Hims & Hers Health has a beta of 2.41, meaning that its stock price is 141% more volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500.
Summary
Hims & Hers Health beats Bullfrog AI on 13 of the 15 factors compared between the two stocks.
About Hims & Hers Health
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
About Bullfrog AI
Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease. The company was founded in 2017 and is based in Gaithersburg, Maryland.
Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.
